(Q41507873)

1 October 2017

1 reference

title

The effects of hormone replacement therapy on coronary heart disease (English)

1 reference

Hormone Replacement Therapy

1 October 2017

1 reference

Sotelo MM

1

1 reference

PubMed ID

9193886

1 October 2017

Johnson SR

series ordinal

2

1 reference

1 October 2017

1 June 1997

1 reference

Endocrinology and Metabolism Clinics of North America

1 October 2017

1 reference

1 October 2017

26

1 reference

1 October 2017

2

1 reference

1 October 2017

313-328

1 reference

Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Postmenopausal estrogen and prevention bias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Estrogen and coronary heart disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Long-term survival after coronary heart disease. Comparisons between men and women in a national sample

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Prevalence and determinants of estrogen replacement therapy in elderly women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Hormone replacement therapy in a risk-benefit perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Reduced mortality associated with long-term postmenopausal estrogen therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984-1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

How do we explain the clinical benefits of estrogen? From bedside to bench

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Are women using postmenopausal estrogens? A community survey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Should older women use estrogen replacement?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Menopause and risk of cardiovascular disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Effects of Conjugated Equine Estrogen With and Without Three Different Progestogens on Lipoproteins, High-Density Lipoprotein Subfractions, and Apolipoprotein A-I

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Long-term effects of hormone replacement therapy on Doppler-derived parameters of aortic flow in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Estrogen and cardiovascular function after menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Association of Exogenous Estrogen and Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Coronary arteriography in estrogen-treated postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

The impact of female hormone usage on the lipid profile. The Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Induction of calcium-dependent nitric oxide synthases by sex hormones.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Estrogen: effects on the cardiovascular tree

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970249-8

7 January 2021

10.1016/S0889-8529(05)70249-8

Identifiers

DOI

1 reference

1 October 2017

1 reference

PubMed ID

9193886